New Hartford, NY, United States of America

Charles Antzelevitch

USPTO Granted Patents = 7 


 

Average Co-Inventor Count = 3.1

ph-index = 3

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2009-2015

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovations of Charles Antzelevitch

Introduction

Charles Antzelevitch is a prominent inventor based in New Hartford, NY (US). He has made significant contributions to the field of medicine, particularly in the treatment of atrial fibrillation. With a total of 7 patents to his name, Antzelevitch's work has had a profound impact on cardiac health.

Latest Patents

One of his latest patents is a method for treating atrial fibrillation. This invention relates to a method for the treatment or prevention of atrial fibrillation and/or atrial flutter. It involves the coadministration of a synergistically therapeutic amount of dronedarone or a pharmaceutically acceptable salt and a synergistically therapeutic amount of ranolazine or a pharmaceutically acceptable salt. Additionally, the patent provides methods for modulating ventricular and atrial rhythm and rate. It also includes pharmaceutical formulations suitable for such combined administration.

Career Highlights

Throughout his career, Antzelevitch has worked with notable companies such as Gilead Sciences, Inc. and the Masonic Medical Research Laboratory. His expertise in cardiac research has positioned him as a leader in his field.

Collaborations

Antzelevitch has collaborated with esteemed colleagues, including Luiz Belardinelli and Alexander Burashnikov. These partnerships have furthered his research and innovations in cardiac health.

Conclusion

Charles Antzelevitch's contributions to the field of medicine, particularly in the treatment of atrial fibrillation, highlight his innovative spirit and dedication to improving patient outcomes. His patents and collaborations reflect a commitment to advancing cardiac health through scientific research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…